OneThree Biotech is a startup that uses a biology-driven artificial intelligence (AI) platform to optimize pre-clinical drug discovery and development. The company was founded by Neel S. Madhukar, Ph.D., Olivier Elemento, Ph.D., Coryandar Gilvary, Ph.D., and Bradlay Pryde. They were selected as part of the 2020 class of startups for Grand Central Tech and the platform has won awards such as 'Most Innovative Technology' award at the 2019 InnoHubei International Science and Technology Innovation and Entrepreneurship Competition. The technology has also been validated through a Phase 2 trial in H3K27M glioblastoma.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/26/20 | $2,500,000 | Seed |
Meridian Street Capital Primary Venture Partners | undisclosed |
